Comparison of protocols efficacy in poor responders: differences in oocytes/embryos competence with different protocols, a retrospective study

Fertility and Sterility

Volumn 91, Issue 4 SUPPL., 2009, Pages 1431-1433

  Manno, Massimo ^a   Tomei, Francesco ^a   Cervi, Marta ^a   Favretti, Cristina ^a   Adamo, Valter ^a  

^a Pordenone Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN ANTAGONIST; HUMAN MENOPAUSAL GONADOTROPIN; ORAL CONTRACEPTIVE AGENT; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE; TRIPTORELIN;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; EMBRYO; FEMALE; FEMALE INFERTILITY; HORMONE RELEASE; HUMAN; IMPLANTATION; INTRACYTOPLASMIC SPERM INJECTION; OOCYTE; PREGNANCY RATE; PRIORITY JOURNAL; PROGNOSIS; TREATMENT RESPONSE;

ADULT; CHORIONIC GONADOTROPIN; CLINICAL PROTOCOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO TRANSFER; EMBRYONIC DEVELOPMENT; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; LUTEOLYTIC AGENTS; OOCYTES; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; RETROSPECTIVE STUDIES; SPERM INJECTIONS, INTRACYTOPLASMIC; TRIPTORELIN;

EID: 63249136818     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.06.001     Document Type: Article

References (22)

1. Turhan N.O. Poor response-the devil is in the definition. Fertil Steril 86 (2006) 777
2. Tarlatzis B.C., Zepiridis L., Grimbizis G., and Bontis J. Clinical management of low ovarian response to stimulation for IVF: a systematic review. Hum Reprod Update 9 (2003) 61-76
3. Shanbhag S., Aucott L., Bhattacharya S., and Hamilton M.A. Mc Tavish AR. Interventions for "poor responders" to controlled ovarian hyperstimulation (COH) in in-vitro fertilisation (IVF). Cochrane Database Syst Rev 1 (2007) CD004379
4. Mohamed K.A., Davies W.A., Allsopp J., and Lashen H. Agonist "flare up" versus antagonist in the management of poor responders undergoing in vitro fertilization treatment. Fertil Steril 83 (2005) 331-335
5. Cheung L.P., Lam P.M., Lok I.H., Chiu T.T., Yeung S.Y., Tjer C.C., et al. GnRH antagonist versus long GnRH agonist protocol in poor responders undergoing IVF: a randomized controlled trial. Hum Reprod 20 (2005) 616-621
6. Mochtar M.H., Van der Veen O., Ziech M., and van Wely M. Recombinant luteinizing hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles. Cochrane Database Syst Rev 2 (2007) CD005070
7. Barrenetxea G., Agirregoikoa J.A., Jimenez M.R., de Larruzea A.L., Ganzabal T., and Carbonero K. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles. Fertil Steril 89 (2008) 546-553
8. Balasch J., Fabregues F., Penarrubia J., Carmona F., Casamitjana R., Creus M., et al. Pretreatment with transdermal testosterone may improve ovarian response to gonadotropins in poor responders IVF patients with normal basal concentration of FSH. Hum Reprod 21 (2006) 1884-1893
9. Mitwally M.F., and Casper R.F. Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders. Fertil Steril 77 (2002) 776-780
10. Lossl K., Andersen A.N., Loft A., Freiesleben N.L., Bangsboll S., and Andersen C.Y. Androgen priming using aromatase inhibitor and hCG during early follicular phase GnRH antagonist down regulation in modified antagonist protocols. Hum Reprod 21 (2006) 2593-2600
11. Choj J.H., Gilks C.B., Auersperg N., and Leung P.C. Immunolocalization of gonadotropin-releasing hormone (GnRH)-I, (GnRH)-II, and GnRH receptor during follicular development in human ovary. J Clin Endocrinol Metab 91 (2006) 4562-4570
12. Mohamed K.A., Davies W.A., and Lashen H. Dynamics of pituitary down-regulation and ovarian response to controlled stimulation in in vitro fertilization cycles. Fertil Steril 87 (2007) 433-435
13. Franco Jr. J.G., Baruffi R.L., Mauri A.L., Petersen C.G., Felipe V., Cornicelli J., et al. GnRH agonist versus GnRH antagonist in poor ovarian responders: a meta-analysis. Reprod Biomed Online 13 (2006) 618-627
14. Weil S., Vendola K., Zhou J., and Bondy C.A. Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development. J Clin Endocrinol Metab 84 (1999) 2951-2956
15. Ziebe S., Lundin K., Janseens R., Helmgaard L., and Arce J.C. Influence of ovarian stimulation with HP-hMG or recombinant FSH on embryo quality parameters in patients undergoing IVF. Hum Reprod 22 (2007) 2404-2413
16. Casan E.M., Raga F., Bonilla-Musoles F., and Lake Polan M. Human oviductal gonadotropin-releasing hormone: possible implications in fertilization, early embryonic development, and implantation. J Clin Endocrinol Metab 85 (2000) 1377-1381
17. Kawamura K., Fukuda J., Kumagai J., Shimizu Y., Kodama H., Nakamura A., et al. Gonadotropin-releasing hormone I analog acts as an antiapoptotic factor in mouse blastocysts. Endocrinology 146 (2005) 4105-4116
18. Klinkert E.R., Broekmans F.J.M., Looman C.W.N., Habbema J.D.F., and teVelde E.R. Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial. Hum Reprod 20 (2005) 611-615
19. Raga F., Casan E.M., Kruessel J., Wen Y., Bonilla-Musoles F., and Polan M.L. The role of gonadotropin-releasing hormone in murine preimplantation embryonic development. Endocrinology 140 (1999) 3705-3712
20. Chou C.S., Zhu H., MacCalman C.D., and Leung P.C.K. Regulatory effects of gonadotropin-releasing hormone (GnRH) I and GnRH II on the levels of matrix metalloproteinase (MMP)-2, MMP-9, and tissue inhibitor of metalloproteinases-1 in primary cultures of human extravillous cytotrophoblasts. J Clin Endocrinol Metab 88 (2003) 4781-4790
21. Raga F., Casan E.M., Wen Y., Huang H.Y., Musoles F.B., and Polan M.L. Dependent regulation of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-3 in human endometrial stromal cells by gonadotropin-releasing hormone implications in early human implantation. J Clin Endocrinol Metab 84 (1999) 636-642
22. Mitwally M.H.M., Bhakoo H.S., Crickard K., Sullivan M.W., Batt R.E., and Yeh J. Estradiol production during controlled ovarian hyperstimulation correlates with treatment outcome in women undergoing in vitro fertilization-embryo transfer. Fertil Steril 86 (2006) 588-596